REST/NRSF 通过抑制替代细胞命运来保护肌肉干细胞的身份
Korin Sahinyan1,2, Darren M Blackburn3, Marie-Michelle Simon1,4
1Department of Human Genetics, McGill University, 3640 rue University, Montréal, QC, Canada.
Nature communications
|August 12, 2025
概括
抑制素-1沉默转录因子 (REST) 通过抑制非肌肉基因来保护肌肉干细胞的身份. 失去REST会影响肌肉再生和干细胞池的维护.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 细胞生物学 细胞生物学
- 发展生物学 发展生物学
背景情况:
- 细胞命运的确定需要精确的基因激活和抑制.
- 骨肌干细胞依赖于肌源性调节因子来激活,但抑制机制的理解较少.
- 表观遗传调节器REST (抑制剂元素-1沉默转录因子) 参与了基因沉默.
研究的目的:
- 研究REST在骨肌干细胞中抑制非肌肉基因中的作用.
- 确定REST损失对肌肉干细胞身份,分化和再生的影响.
主要方法:
- 在小鼠骨肌干细胞中,CRISPR-Cas9介导的REST被淘汰.
- 染色体免疫沉测序 (ChIP-seq) 用于评估REST结合和染色体可访问性.
- RNA测序 (RNA-seq) 用于分析基因表达特征.
- 在REST缺乏小鼠肌肉再生和肌纤维生长的体内研究.
主要成果:
- 在骨肌干细胞中,REST积极抑制许多非血统基因,即使是那些具有宽容色素的基因.
- 失去REST功能会破坏肌肉特定的表观遗传和转录特征.
- 缺少REST导致分化受损,前代细胞的亡增加,以及干细胞池的枯竭.
- 缺乏REST的小鼠表现出骨肌肉再生受损和产后肌纤维生长减少.
结论:
- REST是一个关键的表观遗传调节器,对于维持骨肌肉干细胞身份至关重要.
- 通过积极抑制非肌肉和发育调节的基因,REST保护干细胞的身份.
- REST的调节失调会影响肌肉干细胞功能,导致再生和生长受损.
相关概念视频
Stem Cell Niche
5.3K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.3K
Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Multipotency and Niche of Bulge Stem Cell
3.8K
A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...
3.8K
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K


